CD8A and HIV infectious disease: Although the CD4+ T-cell count remains a robust predictor of mortality, both in those on and not on ART [23], immune responses to antiretroviral treatment of HIV infection are varied and involve changes in both CD4+ and CD8+ T-cell repertoires, both of which are incorporated into the CD4+/CD8+ T-cell ratio.